durapatite has been researched along with Multiple Myeloma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baykov, V; Borset, M; Dalas, E; Dobra, K; Hjerpe, A; Kanakis, I; Karamanos, NK; Labropoulou, V; Seidel, C; Sundan, A; Theocharis, AD | 1 |
| Sager, RD; Theis, RM | 1 |
2 other study(ies) available for durapatite and Multiple Myeloma
| Article | Year |
|---|---|
Serglycin constitutively secreted by myeloma plasma cells is a potent inhibitor of bone mineralization in vitro.
Topics: Calcification, Physiologic; Cell Line, Tumor; Durapatite; Humans; Multiple Myeloma; Plasma Cells; Protein Conformation; Proteoglycans; Vesicular Transport Proteins | 2006 |
Dental implants placed in a patient with multiple myeloma: report of case.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dental Implantation, Endosseous; Dental Implants; Denture Design; Denture, Partial, Fixed; Durapatite; Humans; Hydroxyapatites; Jaw, Edentulous, Partially; Male; Maxilla; Multiple Myeloma; Patient Care Planning | 1990 |